SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Access to medicines after TRIPS: Is compulsory licensing an effective mechanism to lower drug prices? A review of the existing evidence
14 references·2 citing·47 second hop
Access to medicines after TRIPS: Is compulsory licensing an effective mechanism to lower drug prices? A review of the existing evidence (2020)Access to medicines after TRIPS: Is compu…Systematic Reviews and Meta-Analyses (2019)Systematic Reviews and Meta-A…Can breakthrough innovations serve the poor (bop) and create reputational (CSR) value? Indian case studies (2013)Can breakthrough innovations …Trends in Compulsory Licensing of Pharmaceuticals Since the Doha Declaration: A Database Analysis (2012)Trends in Compulsory Licensin…Secondary Patenting Of Branded Pharmaceuticals: A Case Study Of How Patents On Two HIV Drugs Could Be Extended For Decades (2012)Secondary Patenting Of Brande…Driving a decade of change: HIV/AIDS, patents and access to medicines for all (2011)Driving a decade of change: H…Doing your literature review: traditional and systematic techniques (2011)Doing your literature review:…Doing Your Literature Review: Traditional and Systematic Techniques (2011)Doing Your Literature Review:…Global Pharmaceutical Markets and Corporate Citizenship: The Case of Novartis’ Anti-cancer Drug Glivec (2008)Global Pharmaceutical Markets…Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and Thailand (2007)Sustaining access to antiretr…From Imitation to Innovation: The Evolution of R&D Capabilities and Learning Processes in the Indian Pharmaceutical Industry (2007)From Imitation to Innovation:…Systematic reviews in the social sciences: a practical guide (2006)Systematic reviews in the soc…Compulsory licences: recent experiences in developing countries (2006)Compulsory licences: recent e…The TRIPS Agreement: Drafting History and Analysis (2003)The TRIPS Agreement: Drafting…Post-TRIPS Options for Access to Patented Medicines in Developing Nations (2002)Post-TRIPS Options for Access…Resolving the patents paradox in the era of COVID-19 and climate change: Towards a patents taxonomy (2023)Resolving the patents paradox…‘No-one is Safe Until Everyone is Safe’ – Patent Waiver, Compulsory Licensing and COVID-19 (2021)‘No-one is Safe Until Everyon…The Reflective Practitioner: How Professionals Think in Action (1985)Bias in meta-analysis detected by a simple, graphical test (1997)Measuring inconsistency in meta-analyses (2003)Methods for the thematic synthesis of qualitative research in systematic reviews (2008)Guidance on Conducting a Systematic Literature Review (2017)The Handbook of Research Synthesis and Meta-Analysis (2019)Assessing the quality of reports of randomized clinical trials: Is blinding necessary? (1996)Methods of Evidence-Based Anatomy: a guide to conducting systematic reviews and meta-analysis of anatomical studies (2016)Flipped classroom in English language teaching: a systematic review (2019)Systematic review of innovative work behavior concepts and contributions (2021)The Economics of Imperfect Competition. (1934)Industrial Market Structure and Economic Performance. (1971)Appropriating the Returns from Industrial Research and Development (1987)Patents, Price Controls, and Access to New Drugs: How Policy Affects Global Market Entry (2005)The Patents-Based Pharmaceutical Development Process (2005)An Economic Justification for Open Access to Essential Medicine Patents in Developing Countries (2009)An Evolutionary Theory of Economic Change (1983)Absorptive Capacity: A New Perspective on Learning and Innovation (1990)Case Study Research: Design and Methods (1991)Beyond technological catch-up: An empirical investigation of further innovative capability accumulation outcomes in latecomer firms with evidence from Brazil (2013)Internationalization of emerging Indian multinationals: Linkage, leverage and learning (LLL) perspective (2015)Relationship between international experience and innovation performance: T he importance of organizational learning for EMNE s (2017)The Gift: The Form and Reason for Exchange in Archaic Societies. (1992)Global assemblages: technology, politics, and ethics as anthropological problems (2005)Politics of life itself: biomedicine, power and subjectivity in the twenty-first century (2006)The Unlicensed Lives of Antidepressants in India: Generic Drugs, Unqualified Practitioners, and Floating Prescriptions (2009)Knowledge, legitimacy and economic practice in informal markets for medicine: A critical review of research (2010)The judicialization of biopolitics: Claiming the right to pharmaceuticals in Brazilian courts (2013)Can Patents Deter Innovation? The Anticommons in Biomedical Research (1998)Information Feudalism: Who Owns the Knowledge Economy? (2003)Private Power, Public Law (2003)Making technological innovation work for sustainable development (2016)Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis (2016)Prevalence of non-communicable diseases and access to care among non-camp Syrian refugees in northern Jordan (2018)How Do Patents And Economic Policies Affect Access To Essential Medicines In Developing Countries? (2004)Trade, TRIPS, and pharmaceuticals (2009)WHO Model Lists of Essential Medicines (2016)ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe (2017)Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001–2016 (2018)What is the impact of intellectual property rules on access to medicines? A systematic review (2022)Knowledge management in SMEs: a literature review (2012)A Framework for Guiding and Evaluating Literature Reviews (2015)Tips to use partial least squares structural equation modelling (PLS-SEM) in knowledge management (2018)The Socio-Economics of Geographical Indications (2004)Patent rights and innovative activity: evidence from national and firm-level data (2007)Sample Selection in Systematic Literature Reviews of Management Research (2021)How to design bibliometric research: an overview and a framework proposal (2024)
this work references cited by second hop

References

  • 2006Systematic reviews in the social sciences: a practical guide4,089 cited
  • 2011Doing your literature review: traditional and systematic techniques753 cited
  • 2011Doing Your Literature Review: Traditional and Systematic Techniques639 cited
  • 2003The TRIPS Agreement: Drafting History and Analysis397 cited
  • 2011Driving a decade of change: HIV/AIDS, patents and access to medicines for all334 cited
  • 2019Systematic Reviews and Meta-Analyses330 cited
  • 2007From Imitation to Innovation: The Evolution of R&D Capabilities and Learning Processes in the Indian Pharmaceutical Industry194 cited
  • 2002Post-TRIPS Options for Access to Patented Medicines in Developing Nations175 cited
  • 2008Global Pharmaceutical Markets and Corporate Citizenship: The Case of Novartis’ Anti-cancer Drug Glivec166 cited
  • 2012Trends in Compulsory Licensing of Pharmaceuticals Since the Doha Declaration: A Database Analysis166 cited
  • 2007Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and Thailand158 cited
  • 2012Secondary Patenting Of Branded Pharmaceuticals: A Case Study Of How Patents On Two HIV Drugs Could Be Extended For Decades104 cited
  • 2013Can breakthrough innovations serve the poor (bop) and create reputational (CSR) value? Indian case studies74 cited
  • 2006Compulsory licences: recent experiences in developing countries

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

17 cited

Cited by

  • 2021‘No-one is Safe Until Everyone is Safe’ – Patent Waiver, Compulsory Licensing and COVID-1912 cited
  • 2023Resolving the patents paradox in the era of COVID-19 and climate change: Towards a patents taxonomy7 cited